ACTA1 and chronic kidney disease: We therefore analyzed the α-SMA expression immunohistochemically, using a monoclonal antibody against α-SMA and renal biopsy tissues sampled repeated from 6 PSAGN patients, 3 of whom progressed into CKD, and 3 who were cured.